Selenium, a micronutrient can modulate viral diseases including COVID-19 by Kunwar, A & Priyadarsini, K Indira
Indian Journal of Biochemistry & Biophysics 
Vol. 57, December 2020, pp. 713-723 
Selenium, a micronutrient can modulate viral diseases including COVID-19 
A Kunwar
1,2
* & K Indira Priyadarsini
3
* 
1Radiation & Photochemistry Division, Bhabha Atomic Research Centre, Mumbai-400 085, Maharashtra, India 
2Homi Bhabha National Institute, Anushaktinagar, Mumbai-400 094, Maharashtra, India 
3UM-DAE Centre for Excellence in Basic Sciences, University of Mumbai, Vidyanagari Campus, Mumbai-400 098, Maharashtra, India 
Received 12 June 2020; revised 24 June 2020 
Selenium, a micronutrient is reported to play a very important role in fighting bacterial and viral infections. Selenium 
exerts its effects through incorporation into selenoproteins that are crucial for providing antioxidant defense and maintaining 
redox homeostasis. The deficiency of selenium in the diet leads to impaired immune response and increased pathogenesis of 
viral diseases. On the other hand, supplementation with selenium has been shown to be very effective in reducing infections 
and mortality against many pathogenic RNA viruses. This has encouraged researchers across the world to examine the role 
of selenium (if any) in the susceptibility and/or severity of the recent outbreak of coronavirus disease (COVID-19). Some of 
the emerging findings along with the future scope of research on using selenium for management of viral infections 
including COVID-19 are discussed.  
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Selenium is the 34
th
 element belonging to Group 16 of 
the Periodic Table, which is also known as 
chalcogenide. Unlike other important elements of the 
group, oxygen, and sulfur, selenium is less abundant 
and a lesser-known element in biology and medicine. 
For quite some time, selenium was considered as the 
highly toxic element and several disorders, including 
cancers in humans, and animals have been attributed 
to the bioaccumulation of selenium
1
. If we observe 
the periodic table, it is interesting to note that this 
element is surrounded by more toxic elements like 
arsenic, antimony, tellurium, and bromine. Therefore, 
it is natural to presume that selenium is also toxic. 
This myth was however dispelled by the pioneering 
work of Swartz and Foltz in 1957 revealing that 
selenium is a micronutrient for mammals
2-5
. 
Subsequent research has confirmed the biochemical 
role of this trace element through its incorporation 
into 21
st
 amino-acid known as selenocysteine (SeCys) 
and in turn constituting the active site of an important 
antioxidant enzyme, glutathione peroxidase (GPx)
5-8
. 
The physiological function of GPx is to catalyze the 
reduction of hydrogen peroxide by using glutathione 
as a co-factor. Over the years, researchers have 
identified at least eight different isoforms of GPx in 
mammals, out of which five (GPx1–4 and GPx6) 
are known to contain SeCys in their active site
7
. 
Along with GPx, humans have at least 24 other 
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proteins where SeCys is the constituent, and these  
are often termed as selenoproteins. Selenoprotein family, 
in human, constitute five GPx isoforms, thioredoxin 
reductases, thioredoxin-glutathione reductase, 
iodothyronine deiodinases, selenophosphate synthetase, 
selenoprotein F, selenoprotein H, selenoprotein I, 
selenoprotein K, selenoprotein M, selenoprotein N, 
selenoprotein O, selenoprotein P, methionine 
sulfoxidereductase B1, selenoprotein S, selenoprotein T, 
selenoprotein V and selenoprotein W
5
.  
The incorporation of selenium into selenoproteins 
occurs in a complex biosynthetic pathway catalyzed 
by several enzymes (Fig. 1)
5,9,10
. In brief, dietary 
selenium (organic or inorganic) undergoes reductive 
metabolism to produce hydrogen selenide (H2Se). 
Subsequently, selenophosphatesynthetase converts 
H2Se into selenophosphate which is incorporated  
into selenoproteins. The tRNA responsible for 
encoding SeCys is initially charged with serine by 
seryl-tRNAsynthetase to form seryl-tRNA. The seryl 
moiety is converted to O-phosphoseryl-tRNA by a 
phosphokinase. SeCys synthase replaces oxygen in 
the O-phosphoseryl-tRNA by a selenium atom 
generating selenocysteyl-tRNA. The selenocysteyl-tRNA 
is used for translating UGA codon of the mRNA into 
SeCys for selenoproteins. 
Although UGA usually codes for the termination of 
protein synthesis, it also specifies SeCys in presence of a 
stem–loop structure called SeCys insertion sequence 
(SECIS) element downstream of UGA, in the mRNA  
of selenoproteins
10
. In mammals, the SECIS element  
is found in the 3′ untranslated region (UTR)  
of selenoprotein mRNAs. Apart from SeCys, 
selenomethionine (SeM) is another important selenium- 
containing amino-acid, which is incorporated into 
selenoproteins non-specifically in place of methionine by 
the initiation codon, AUG using methionine-tRNA. The 
nonspecific incorporation of SeM into proteins is more 
common in plants and yeast as they do not have the 
machinery for the biosynthesis of selenoproteins
11
. These 
selenoproteins play many important roles in cells, which 
include thyroid hormone metabolism, SeCys synthesis, 
transportation and storage of selenium, protein folding, 
immune-modulation, and protection from oxidative stress 
by neutralizing oxidizing peroxides, reducing oxidized 
proteins and membranes, controlling redox signaling,  
and maintaining redox homeostasis
5
. All the above 
physiological functions of selenoproteins are mediated 
through SeCys residue present in their active sites.  
SeCys has lower pKa as compared to analogous  
sulphur- containing amino acid, cysteine and therefore is 




Selenium enters the environment through volcanic 
activity, weathering of rocks and soils, groundwater 
transportation, and metabolic uptake and release by 
plants and animals
11
. It enters the food chain through 
plant and meat products. The nutritional supply of 
 
 
Fig. 1 — Schematic of the incorporation of dietary selenium into selenoproteins 
 




selenium for humans depends on the selenium content 
of the soil, where it is mainly present in inorganic 
forms like selenite and selenate. It is subsequently 
accumulated in farmcrops and animals and finally to 
humans through the diet. Natural selenium sources are 
Brazil nuts, nuts, cereals, grains, legumes, selenised 
yeast, drum sticks, onion, garlic etc. Through plant 
products, selenium is taken up predominantly as  
SeM, methylselenocysteine or -glutamyl-selenium-
methylselenocysteine, whereas the meat is the source 
of SeCys
9
. Selenoneine, a new organoselenium 
compound has been identified from sea fish
13
. 
The Recommended Daily Allowance of selenium is 
about 70 µg/day for men and 55-60 µg/day for 
women. Globally dietary selenium intake is usually 
below 55 µg/day. Notably, some European countries 
such as Spain, Greece, Poland have an average intake 
below 40 µg/day while in Argentina it is 32 to  
24 µg/day. Most of the selenium- deficient countries 
have introduced selenium- enriched fertilizers to 
improve the selenium status in farm produce
14
. 
Selenium-enriched functional foods like vegetables, 
grains, eggs, milk, and meat have also been developed 
and introduced by these countries to overcome 
selenium deficiency. Overall, the intake of selenium 
up to 150 µg/day has been suggested to overcome its 
deficiency. According to National Research Council 
of USA, consumption of selenium in the range of  
50 to 200 µg/day is considered safe, although the 
upper limit may vary from country to country. 
Similarly, some reports from China claimed that 
selenium intake even up to 750 µg/day did not 
produce any toxicity
15
. The level of selenium in  
the serum of healthy individuals ranges from 70 to 
187 µg/dL depending on sex and age
15
. Notably, the 
expressions and activities of GPx and selenoprotein  
P in serum are highly responsive to the selenium 
status or availability and is used as an indicator to 
define the selenium deficiency or sufficiency in the 
body
8,15
. The deficiency of selenium has been 
associated with the onset of many chronic diseases 
like heart diseases, cancer etc. 
As the selenium status or level in earth's crust is 
not the same at all the places, the dietary intake and 
bioavailability (serum level) of selenium vary 
significantly in different populations across the globe. 
China for example has two regions, with highly 
different selenium levels in soil
16
. About 72% of 
China (from northeast to southwest in the country) is 
designated by the world health organization (WHO) 
as selenium- deficient which affects over 70 million 
people, resulting in serious health consequences and 
endemic diseases like Keshan (endemic cardiomyopathy) 
and Kaschin-Beck (endemic osteoarthropathy). Dashan 
region located in the south of Anhui province, China is 
known as selenium-enriched area, where acute and 
chronic effects have been reported. Acute selenium 
toxicity causes gastrointestinal, respiratory, and 
cardiovascular problems, while chronic exposure results 
in mental problems, garlic-smelling breath, hair loss, 
fragile nails and excessive tooth decay
1,17
. Further, 
humans and animals consuming selenium-enriched foods 
have shown sporadic cases of selenium toxicity 
(selenosis). Additionally, few reports are indicating that 
selenium intake above the nutritional requirements may 




Selenium and immune functions  
Mammals have the unique ability to protect 
themselves from pathogenic microorganisms by 
mounting an immune responses against them.  
The immune response constitutes of nonspecific 
immunity mediated by mononuclear phagocytes 
(monocytes/macrophages), polymorphonuclear cells 
(such as neutrophils), natural killer (NK) cells, and 
the complement system and specific immunity 
mediated by T (cellular immunity) and B (humoral or 
antibody response) cells. Classically these two types 
of the immune responses are referred to as innate and 
adoptive or acquired immunity, respectively. The 
successful elimination of pathogens from the body 
requires the coordinated functions of all the above 
effectors or cell types involved in innate and adoptive 
immunity. The loss in the functionality or the 
developmental defects in any of the above cell types 
increases the vulnerability of an individual for 
pathogens including bacterial and viral infections
18
. It 
is well established by the researchers that adequate 
nutritional status consisting of macro and 
micronutrients is needed for the optimal development 
and functionality of the immune cells. Selenium has 
been extensively studied for the correlation of its 
status (mainly deficiency) with the immune 
functions
5,6,8,19-22
. These studies have established an 
inverse correlation between selenium deficiency and the 
functionality of the cells of innate and adoptive 
immunity. For example, selenium deficiency in mice 
models is shown to cause cytotoxicity in lymphocytes, 





) of T cells, decrease in the levels of serum IgG and 
IgM concentrations, and antibody responses
6,8
. The 




effect of selenium deficiency on the T cell development 
has been attributed to the decrease in the expression 
of surface receptor- like interleukin 2 receptor (IL2R) 
and/or the loss of affinity of this receptor for its 
ligand, IL2 (a cytokine involved in the proliferation 
and maturation of T cells)
20
. Additionally, selenium 
deficiency also affects the innate immunity by 
reducing the ability of neutrophils to produce reactive 
oxygen species (ROS) needed for pathogen killing, 
decreasing the activity and count of NK cells, and 
inhibiting the phagocytosis of macrophages
19,21
. On the 
other hand, selenium supplementation in experimental 
animal models is shown to enhance immune functions 
by increasing the proliferation and differentiation of T 
cells and the activity of NK cells
6,8
. Indeed there are also 
reports of immune enhancement in human subjects 
through selenium supplementation. In brief, 
supplementation of adult human subjects with selenium 
(100 µg/day) enhanced a number of host immune 
responses like mitogen- activated proliferation of 
lymphocytes, antigen- induced proliferation and 
differential of T cells, increased production of interferon-
gamma (IFN-g), up-regulation of IL-2 receptors, 





Viral infections and selenium 
An effective immune response is necessary for the 
fight against viral infections. Considering the role of 
selenium in immune functions, its deficiency in 
humans or animals is expected to cause vulnerability 
to a wide variety of infections. Indeed, there are many 
reports in the literature, which confirmed that 
selenium deficiency is linked with the increased 
incidence, severity (virulence) and/or progression of 
viral infections
5,6,8
. Most of the human pathogenic 
viruses are ribonucleic acid (RNA) viruses including 
human immune deficiency virus (HIV), hepatitis C 
virus (HCV), Influenza A virus (IAV), poliovirus, 
West Nile virus (WNV), Ebola virus, and currently 
emerging corona viruses (CoV). Since the evolution, 
RNA viruses have shown the ability to mutate very 
fast under infective stages and this accounts for the 
high lethality rate associated with the pathologies 
caused by these viruses. The faster mutation is an 
adoptive strategy acquired by RNA viruses to survive 
under adverse conditions or to overcome the immune 
response of the host cells. 
The earliest observations on the involvement of 
selenium in the progression of viral infections came 
from the study of human subjects with Keshan 
disease. Keshan disease is a pathological condition 
characterized by selenium deficiency, cardio-
myopathy, and predisposition of infection to 
enterovirus. Bai et al. demonstrated that mice fed with 
selenium- deficient grains and infected with a strain 
of Coxsackie virus B4 (isolated from a Keshan 
disease victim), developed severe heart pathology
23
. 
Whereas similar viral infection in mice fed with 
selenium- enriched grains developed only mild heart 
pathology. This suggested that selenium deficiency is 
associated with increased infection of the Coxsackie 
virus and the onset of the pathogenesis of Keshan 
disease. This study also indicated that mice with 
adequate selenium levels showed high expression of 
GPx level in serum and immune cells, activated 
immune response, and prevented from viral 
infections. Similar observations have been reported 
with influenza virus infections, which are known to 
cause lung pathology. The mice deficient in selenium 
status were found to be more susceptible to influenza 
strains (influenza A/Bangkok/1/79/H1N1) and 
represented higher mortality as well as inflammatory 
score in the lung of these mice as compared to those 
with adequate selenium
24
. Notably, these studies also 
reported a decrease in GPx level of the lung of 
selenium-deficient mice and attributed this as one the 
factors responsible for the inflammatory responses in 
the lung following influenza virus infection
8,24
. 
Furthermore, it was also observed that benign 
strains of many viruses infected to selenium-deficient 
hosts were transformed into virulent ones by 
undergoing genetic mutations. Beck and colleagues 
made many important studies and reported that the 
amyocarditic strain of Coxsackie virus B3 (CVB3/0) 
mutated to virulence strain, when inoculated into 
selenium deficient mice
25-27
. The exact mechanism of 
such transformations is not understood. However, it 
was postulated that the reduced activity of antioxidant 
enzymes like GPx under selenium deficiency elevates 
the ROS level within host cells and this in turn causes 
the frequent damage-repair-mutation cycle of viral 
genome. Another explanation could be that impaired 
immune functions under selenium deficiency allows 
faster replication and in turn mutation of viral genome. 
All these hypotheses are still under validation.  
Selenium has also been reported to play a crucial 
role in reducing the virulence of HIV infections
28-31
. 
Human HIV-1 and HIV-2 retroviruses are single-
stranded RNA viruses and infect helper T (CD
4+
) cells 
of individuals and in turn, suppress the adoptive 
immunity leading to the onset of a disease called 
acquired immune deficiency syndrome (AIDS). It has 




been shown that the progression of HIV infection is 
accompanied by a concurrent decrease in plasma 
selenium levels. Such selenium deficient HIV patients 
are almost 20 times more susceptible to HIV-related 
mortality than those with adequate selenium 
levels
28,29
. Similarly, an inverse relation between 
plasma selenium levels and faster disease progression 
and mortality has also been seen in the case of HIV-
infected children
30
. Daily supplementation with 
selenium, in HIV infected subjects, either as selenium 
salts or selenium- rich foods has been reported to 
suppress the viral burden, increase CD-4
+
 T cell 




In the recent past, the outbreak of the Ebola virus 
in West Africa has also been linked with the 
deficiency of selenium in the susceptible population
32
. 
It is still not known whether the decrease in selenium 
status is the cause or effect of viral infections. 
However, researchers have proposed a new 
hypothesis of viral selenoproteins, according to which 
retroviruses can also incorporate selenium into viral 
proteins
33,34
. The group led by Taylor has performed 
extensive computational analysis of the viral proteins 
from HIV and Ebola and has confirmed the presence 
of UGA codon along with the SECIS in their 
genome
33,34
. His group has also suggested that some 
of the viral proteins show very high similarity with 
the mammalian GPx. As per his postulation, the 
growth of HIV viruses within host cells is restricted 
by their selenium status (high versus low). Under 
selenium deficiency, the intracellular environment of 
host cells becomes unfavorable for viral growth due 
to alteration in redox homeostasis. This in turn causes 
viral particles to escape from host cells and to spread 
the infection to neighboring cells. On contrary, 
selenium supplementation in HIV- infected subjects 
induces the expression of selenoproteins and reduces 
the level of oxidative stress in host cells prompting 
viruses to stay as dormant. The inhibition of viral 
multiplication also reduces the chance of their 
genome undergoing a mutation and acquiring 
virulence. Interestingly, Ebola viruses contain genes 
with several of SeCys insertion sites
33
. Therefore, it is 
expected that Ebola virus may compete with the host 
cells for the incorporation of selenium into 
selenoprotein leading to a physiological condition 
termed as ―induced selenium deficiency‖. Indeed, a 
clinical study by Hou et al. indicated that selenium 
can effectively be used to treat an Ebola-like 
hemorrhagic fever
35
. In this study, administration of 
sodium selenite at a very high oral dose (2 mg for 
nineconsecutive days) reduced the death rate from 
100% (untreated) to 37% (treated) in the very severe 
cases, and from 22% to zero in the less severe cases
35
. 
Overall above reports suggest that selenium controls 
the establishment and progression of viral infections 
by modulating the redox state (oxidizing versus 
reducing) and immune functions of host cells through 
antioxidant selenoproteins as presented in (Fig. 2).  
 
CoV and selenium 
Notably, CoV are the class of human pathogenic 
viruses that are known to cause fetal pneumonia- like 
pathology. These viruses have led to three major 





. The first such outbreak was 
seen in the year 2003 with a fatality rate of 10% and 
the causative agent was named as Severe Acute 
Respiratory Syndrome Coronaviruse (SARS-CoV). 
Later in year 2012, another outbreak of CoV- induced 
pneumonia was reported from Arabian countries and 
this was named as Middle East Respiratory Syndrome 
Coronaviruse (MERS-CoV). The fatality rate 
associated with the disease was significantly higher of 
about 35%. Recently by the end of the year 2019, 
several unidentified cases of pneumonia were 
reported from Wuhan, China
37-43
. The viral genome 
analysis from these patients indicated the presence of 
a new variant of CoV named as 2019 novel 
coronavirus (2019-nCov) by WHO on January 12, 
2020. Subsequently, it was found that the genome of 
these viruses shares a very high degree of sequence 
 
 
Fig. 2 — Mechanisms of the antiviral activity of selenium 




homology (80%) with SARS-CoV and accordingly 
renamed by International Virus Classification 
Commission as SARS-CoV-2 on February 11, 2020. 
With the increasing number of infections and  
the spread of this virus to multiple countries,  
WHO named the respiratory disease caused by  
SARS-CoV-2 as COVID-19 and declared this 
outbreak a pandemic on March 11, 2020. At the time of 
writing this article, there are more than 7 million 
confirmed cases of COVID-19 worldwide and more 
than 400,000 deaths. The primary source for the human-
to-human transmission of this virus is respiratory 
droplets from coughing or sneezing patients. The 
mortality rate associated with COVID-19 infections is in 




The prediction about the structure and function of 
SARS-CoV-2 genome encoded proteins along with 
histopathological analysis of SARS-CoV-2 infected 
subjects have revealed some key points related to the 
pathophysiology of COVID-19 (Fig. 3)
37-45
. In brief, 
SARS-CoV-2 has positive- strand RNA as genetic 
material surrounded by a cage or envelop composed 
of lipoprotein. The genome size of SARS-CoV-2 is 
about ~30 Kb (30,000 bases) and carries the 
information of at least 10 open reading frames (ORFs) 
or genes
37
. Of these, ORF1ab translates two 
overlapping polyprotein 1a (PP1a) and polyprotein 
1ab (PP1ab). ORF2-10 translates for viral structural 
proteins: spike (S) protein, envelope (E) protein, 
membrane (M) protein, nucleocapsid (N) protein, and 
other assisting proteins. The S, M, E proteins are 
involved in the formation of the viral coat and the N 
protein is involved in the packaging of the RNA 
genome
39,40
. The polyproteins (PP1a and PP1ab) 
undergo proteolytic cleavage to release function 
proteins involved in viral replication and transcription 
by viral proteases like 3 chymotrypsin-like proteases 
(3CL
pro
) or main protease (M
pro
) which by itself is 
released from polyproteins through autolytic 
cleavage
41
. The S protein present in viral coat 
interacts with surface receptors like angiotensin-
converting enzyme 2 (ACE2) to facilitate its entry and 
to establish the infection of SARS-CoV-2 in host cells 
(like lung epithelium)
39,40
. Considering the wide 
distribution of ACE2 on cell types of different tissue 
origins like intestinal epithelium, endothelial cells of 
blood vessels, kidney epithelial cells, and nerve cells 
 
 
Fig. 3 — Probable SARS-CoV-2 proteins as therapeutic targets for organo selenium compounds 




among others, it is believed that SARS-CoV-2 can 
infect to multiple organs apart from the lung. In 
addition to ACE2, another host protein called as 
transmembrane protease, serine 2 (TMPRSS2) is also 
involved in the entry of SARS-CoV into host cells
42
. 
This protein facilitates the proper docking of S protein 
on the ACE2 of host cells by trimming a part of it 
through proteolytic cleavage. Upon infection, the 
virus uses the host machinery to make new copies of 
its genome, reassembles itself, and comes out from 
the dead host cells to infect another cell. The dead 
lung cells mount an acute inflammatory response 
(classically referred to as pneumonia or cytokine 
storm) marked by the increase in the levels of pro-
inflammatory cytokines like interleukin-6 (IL-6), 
granulocyte-colony stimulating factor (G-CSF), 
interleukin-10 (IL-10), interleukin-17 (IL-17), 
macrophage inflammatory protein 1 alpha (MIP1A), 
tumor necrosis factor (TNFα) among others
43,45
. 
Additionally, the activated immune cells start 
destroying the body’s own cells triggering an 
autoimmune response. This is followed by respiratory 
and multi-organ failure and eventually mortality. 
Since significant clinical benefits were observed 
with selenium supplementation in other similar RNA 
viral infections, researchers have started to examine 
the role of selenium in COVID-19 infections. Quickly 
in the last two to three months, a few papers already 
appeared on this subject. Prof, Rayman from UK 
along with her colleagues from China, in a letter to 
the Editor of the American Journal of Clinical 
Nutrition reported a correlation between selenium 
status and COVID-19 cure rates in few cities of Hubei 
province of China
46
. They used hair selenium 
concentration available in the database for correlating 
with the cure rate from COVID-19 and had two 
significant observations to report. First, the overall 
cure rate was significantly lower (13.2 % vs 40.6%) 
and the death rate was significantly higher (3% vs 
0.6%) inside Hubei Province than that from outside-
Hubei. Further, within Hubei province, Enshi city 
where high selenium status is reported notably had a 
high cure rate of 36.4%. The second interesting 
observation is that Heilongjiang Province in northeast 
China, with very low selenium status (16 µg/day), had 
a much higher death rate, than that of other provinces 
outside Hubei. The authors thus concluded a 
significant inverse association between cure rate and 
background selenium status in different cities of 
China. The authors however suggested validating 
these observations through proper clinical or 
epidemiological studies. 
Apart from these reports, it is also interesting to 
look at the growing evidence about the effect of 
ageing and comorbid conditions on the selenium 
status of an individual
4,47-52
. In this context, 
Robberecht et al. have recently written an in-depth 
review summarizing various studies conducted on 
measuring selenium status in elderly people
47
. This 
group categorically concluded that serum selenium 
level is significantly reduced in an elderly population. 
Similarly, there are also clinical reports indicating that 
the selenium status of individuals suffering from 
chronic diseases is significantly lowered as compared 
to healthy individuals. For example, patients with 
Crohn disease (CD), cardiovascular disease (CVD), 
autoimmune thyroid disease (AITD), cancer and 
radiotherapy are shown to have impaired selenium 
status
4,48-52
. Despite many reports, it is still not clear, 
whether low selenium status is a cause or a 
consequence of the ageing process or disease. 
However, it can be speculated that inadequate 
selenium status in elderly individuals as well as in 
patients with co-morbid conditions like CVD, cancer, 
hypertension and auto-immune disorders may pose a 
higher risk for susceptibility as well as lesser cure rate 
from COVID-19. Therefore it is worth investigating 
such correlation study in the coming years. 
 
Selenium- based therapeutics against COVID-19 
To date no specific therapeutic medicine (herbal or 
allopathic), vaccine, and dietary supplement other than 
social distancing, and proper hygiene practices are 
available to protect from COVID-19. The evolving 
knowledge of the pathophysiology of COVID-19 has 
paved the way for evaluating several treatment 
strategies across the world
37-45,53
. Most of these 
treatment strategies are based on repurposing the 
already existing drugs for other clinical 
indications
37,38,41
. Considering the fact that drugs 
approved by Food and Drug Administration (FDA) are 
known for metabolic characteristics, dosages used, 
potential efficacy, and side effects, repurposing is the 
fastest way to develop medicines for the treatment of 
COVID-19. A few of the treatment approaches being 
used in the clinic to fight COVID-19 are as follows: (1) 
Broad-spectrum antiviral drugs like Remdesivir, 
Favipiravir, Lopinavir, Ritonavir, Viperin, Emodin, 
and Promazine among others being considered for  
the treatment of COVID-19. These drugs interfere with 




the entry and molecular biology of the virus in the  
host cells
43,45
. (2) Anti-inflammatory drugs like 
glucocorticoids, IL-6 antagonists, and JAK inhibitors 
are being evaluated for efficacy against COVID-19
43,45
. 
These drugs suppress the inflammatory response or 
pneumonia associated with COVID-19 (3) As per the 
recent trials conducted in France, USA, China, and 
India (Jaipur hospital), hydroxychloroquine has shown 
potential for the treatment of COVID-19
43,45,53,54
. It has 
known anti-viral as well as anti-inflammatory 
activities. The combination of these activities is 
proposed to be responsible for its efficacy against 
COVID-19. However, there are also some concerns 
related to side effects (heart disorders) associated with 
this drug. (4) Bacillus Calmette–Guérin (BCG) vaccine 
against bacterium Mycobacterium tuberculosis is 
known to enhance the general immune response of a 
person against all kinds of infection including viruses. 
Recently few studies from the USA have reported a 
significantly lower infection and mortality rate and 
appearance of less severe symptoms among COVID-19 
infected patients in countries, where BCG 
immunization is compulsory for all individuals as part 
of their health care programme
55
. Based on these 
observations, BCG vaccination is being suggested as 
the prophylactic measure against COVID-19. (5) The 
use of plasma from patients with COVID-19, who have 
made a full recovery (convalescent plasma) is another 
option being evaluated for management of COVID-19 
globally
38,43,45
. Although, above treatment strategies 
have shown considerable success in the clinical setting, 
none of these have been approved by the FDA as a 
standard treatment protocol for COVID-19. This has 
kept all global pharmaceutical companies in the hunt 
for vaccine or specific drug against COVID-19.  
Extensive research over the years has established that 
selenium in organic form is less toxic as compared to 
inorganic form and this has paved the way for a new 
research direction evaluating organoselenium- based 
compounds as potential therapeutic agents
4,56
. In this 
regard, a several organoselenium compounds such as 
ebselen, diphenyldiselenide (DPD), diselenodipropionic 
acid (DSePA), selenoglutathione (GSeSeG), dihydroxy-
1-selenolane (DHS), methylseleninic acid (MSA) and 1,4 
phenylenebis(methylene)selenocyanate among others are 
reported in the literature for various pharmacological 
activities ranging from antioxidant, anti-inflammatory, 
anticancer and radio-protective activities
4,56
. Ebselen is 
the most potent among the synthetic selenium 
compounds, which has been reported for excellent GPx-
like activity in pre-clinical models
57
. It has also been 
demonstrated for anti-inflammatory, anti-cancer, and 
anti-oxidant properties using in vivo models. It is a 
modest immune-stimulant and induces several 
interleukins including interleukin-1 (IL-1), IL-6, IL-10 
and interleukin-18 (IL-18). Ebselen has good blood-brain 
permeability and rapid absorption following oral 
administration. A number of studies demonstrated that 
ebselen attenuates neuronal cell death induced by 
ischemia/reperfusion. At present this compound has been 
approved by the FDA for the treatment of neurological 
bipolar disease/hearing loss and is also under clinical 
trials for the management of various other diseases. 
Similarly, our group has also been associated with the 
development of organoselenium compounds with the 
specific application as drugs for cancer radiotherapy
4
. 
One such compound, DSePA showed excellent results in 
preventing radiation-induced pneumonitis, one of the 
serious side effects of thoracic radiotherapy
4,58,59
. 
Mechanistically DSePA specifically increases selenium 
level in the lung tissue, elevates GPx level in the lung, 
and significantly reduces the radiation-mediated 
infiltration of polymorphonuclear neutrophils (PMN) and 
elevation in levels of cytokines such as G-CSF, 
interleukin-1-β (IL1-β), intracellular adhesion molecule-1 
(ICAM-1), E-selectin, IL-17 and tumor growth factor-β 
(TGF-β) in the lung
58
. Additionally, the molecule also 
gains significance, as it is orally administrable. The lethal 
dose (LD50) of DSePA is considerably higher than the 
known organoselenium compounds like SeM and methyl 




Apart from the above pharmacological activities, the 
design and development of organoselenium-based 
therapeutics for anti-viral activities is also a fast-
emerging area of research. The basic principle of 
designing such compounds is to use them as inhibitors to 
target viral proteins involved in entry, replication, and 
transcription within the host cells. The advantage of 
using viral proteins as targets is to improve the specificity 
of drugs as well as to reduce the side effect due to the 
absence of closely related homologues in humans. In the 
recent past, many synthetic organoselenium compounds 
such as diselenodi benzamides have been synthesized 
and evaluated for anti-HIV activity
60
. In brief, these 
compounds were reported to inhibit NCp7, a conserved 
retroviral protein of HIV that exerts essential and 
multiple functions in both early and late stages of viral 
replication. Similarly, a recent publication in ―Nature 
journal‖ by a research group from China indicated that 




synthetic organoselenium compounds could be  potential 
candidate drug molecules for the management of 
COVID-19
41
. This group specifically proposed that the 
viral protein M
pro 
involved in the processing of the 
replicase proteins of SARS-CoV-2 is an attractive target 
to design drugs against COVID-19 (Fig. 3). Accordingly, 
the group performed structure-based docking of over 
10000 FDA- approved drugs and other 
pharmacologically active compounds including Ebselen 
(organoselenium compound) as an inhibitor of M
pro
. 
Subsequently, the most potent compounds were 
evaluated for anti-viral activities using recombinant M
pro 
and the cellular infection models of SARS-CoV-2. 
Additionally, the crystal structure of the inhibitor-protein 
(M
pro
) complex was also established. Based on these-
analysis, authors identified six compounds namely 
Ebselen, Disufiram, Tideglusib, Crmofur, Shikonin,and 
PX12 as potent inhibitors of the activity of M
pro
 with IC50 
(50% inhibitory concentration) values ranging from 0.67 
to 21.4 µM. Of these Ebselen was the best in terms of 
reducing the viral load in the cellular studies. This 
inhibitory action of Ebselen was mediated through its 




 residues present in the 
active site of M
pro
. Finally, the authors concluded that 
Ebselen being FDA- approved drug is a candidate 
molecule for repurposing against COVID-19. This is  
landmark research and encourages synthetic researchers 
across the world to design newer and more potent 
organoselenium based derivatives for inhibition of  
viral proteins. Along with M
pro
, another important  
SARS-CoV-2 protein which could be the possible targets 
of the organoselenium compound is S protein as it is 
involved in the viral entry into host cells (Fig 3). 
Additionally, it would also be worth evaluating 
organoselenium compounds for possible inhibition of 
host proteins such as ACE2 and/or TMPRSS2 (Fig. 3). 
However, these proteins are also involved in the normal 
functioning of various cell types and therefore side 
effects arising from the inhibition of these proteins may 
be a concern in drug development
37,39,40
. Finally, the 
pathogenesis of COVID-19 is marked by an acute 
inflammatory response and therefore several of synthetic 
organoselenium compounds including DSePA reported 
for anti-inflammatory activity in the lung may also be 
effective in suppressing or delaying pneumonia 
associated with COVID-19. However, this hypothesis 
needs to be rigorously tested using preclinical models.  
 
Conclusion 
The trace levels of several elements are required to 
maintain the redox and energy balance in the living 
systems. Selenium is one such trace element that has 
been proposed to be crucial not only for normal 
physiology but also for immunity to fight viral 
infections. Its function is mediated by the synthesis of 
selenoproteins. 
Currently, when we are fighting the pandemic, we 
must contemplate and evaluate ourselves, where we as 
Indians stand as far as selenium nutrition is concerned. 
There is no systematic data on the statistics and mapping 
of selenium status in the Indian population, except for 
one study in some districts of the northern region
61
. This 
sole study documented that selenium levels were above 
normal where the soils are drier, alkaline, and less water 
is available for irrigation, while the soils of Punjab and 
Himachal Pradesh states showed low to normal levels, 
where plenty of irrigation water is available. An 
immediate task, therefore, is to evaluate selenium status 
among different populations and clusters and correct the 
deficiency if any through necessary supplementation. 
Since significant clinical benefits are achieved by 
supplementation through inorganic selenium compounds, 
the possibility of supplementation through organic forms 
should be explored. Organic selenium has the advantage 
of being less toxic than the inorganic forms. 
Additionally, new research has to be initiated to 
explore the possibility of new selenium-based 
compounds for specific targeting of viral proteins. Initial 
promising results with Ebselen can be used as a possible 
themes for developing organoselenium- based drugs not 
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